Медико-биологический
информационный портал
для специалистов
 
БИОМЕДИЦИНСКИЙ ЖУРНАЛ Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г.  2020 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"
(ФГБУН ИТ ФМБА России)

Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 15, Art. 33 (pp. 394-403)    |    2014       
»

Design and analysis of application of minimal extracorporeal circuit to perform hyperthermic intraperitoneal chemoperfusion in experimental settings
Belayev A.M., Solovyev I.A., Senchik K.Y., Alekseev V.V., Kireeva G.S. Guseinov K.D., Belayeva O.A.

Department of naval surgery of S.M. Kirov Military Medical Academy, Saint Petersburg, Russia



Brief summary

Hyperthermic intraperitoneal chemoperfusion (HIPEC) is a high-tech modern treatment modality for patients with peritoneal carcinomatosis from the tumors affecting the peritoneum. Technical challenges associated with this procedure cause the search and introduction of new concepts of HIPEC. Minimal extracorporeal circuit (mec) is one of them. The aim of the study was to develop minimal extracorporeal circuit to perform HIPEC and to conduct comparative analysis of its efficacy in a rat model of peritoneal carcinomatosis from ovarian cancer. The study was carried out in 32 female outbred Wistar rats with ascetic ovarian cancer which was inoculated intraperitoneally at a certain amount of ovarian cancer cells. Following inoculation rats were randomized into two groups: group I – control, HIPEC with cisplatin (20 mg/kg body weight) performed according to the previously created thechnique (n-17), group II – HIPEC with cisplatin (20 mg/kg body weight) using mec and laser transmitter (n=15). In both groups HIPEC was performed in 48 hours after ovarian cancer inoculation. Experimental perfusion model of HIPEC incorporated mec was developed and successfully tested and its main advantages such as less number of postoperative complications and improved survival of rats with advanced ovarian cancer compared to HIPEC without mec were demonstrated in the study.


Key words

peritoneal carcinomatosis, ovarian cancer, hyperthermic intraperitoneal chemoperfusion (HIPEC), minimal extracorporeal circuit (mec).





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Belyaeva O.A. Himioperfyzionnoe lechenie zlokachestvennih opyholei / O.A. Belyaeva, V.G. Bespalov, K.U. Senchik, S.A. Konkov, A.N. Stykov, Ya.G. Myrazov, V.A. Aleksandrov // Medlain ekspress. – 2011. – № 2–3. – S.58–65


2. Belyaeva O.A., V.G. Bespalov, K.U. Senchik, G.S. Kireeva, A.N. Stykov, V.A. Aristova, A.O. Ivancov, E.A. Vishinskaya, M.A. Maidin, A.L. Semenov, V.A. Aleksandrov Eksperimentalnaya tehnologiya himioperfyzionnogo lecheniya kanceromatoza brushnoi polosti pri rake yaichnika // Vopr. onkol. – 2014. – T.60, №1. – S. 71–78


3. Yrmancheeva A.F. Opyholi yaichnika (klinika, diagnostika i lechenie) / A.F. Yrmancheeva, G.F. Kytysheva, E.A. Ylrih. – SPb.: Izd-vo N-L, 2012. – 68 s.


4. Chan D. L. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy / D. L. Chan, D. L. Morris, A. Rao, T. C. Chua // Cancer Manag. Res. – 2012. – Vol. 4. – P. 413–422


5. Chua T.C. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results / T.C. Chua, G. Robertson, W. Liauw, R. Farrell, T.D. Yan, D.L. Morris // J. Cancer Res. Clin. Oncol. – 2009. – Vol. 135. – P. 1637–1645


6. Halkia E. Diagnosis and management of Peritoneal Metastases from ovarian cancer / E. Halkia, J. Spiliotis, P. Sugarbaker // Gastroenterology research and practice. – 2012. – 2012. – 12 pp.


7. Helm C.W. HIPEC in ovarian cancer: first report of HYPER-O registry / C. W. Helm, S. D. Richard, J. Pan et al. // International Journal of Gynecological Cancer. – 2010. – Vol. 20, №1. – P. 61–69


8. Helm C.W. The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer / C.W. Helm // The Oncologist. – 2009. – Vol. 14. – P. 683–694


9. Valtonen M., Vahasilta T., Kaila-Keinanen T., Kutilla K. New mini-extracorporeal circulation system (ECC.O) is a safe technique in coronary surgery / Scand Cardiovasc J. – 207. – 45 (1). – P. 345-350


10. Witkamp A.M., de Bree E., Van Goethem A.R., F. A. N. Zoetmulder Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy // Cancer treatment reviews. – 2001. – 27. – P. 365-374



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100